CD8A and neoplasm: Also, studies using the Ty21a vaccine strain in a bladder cancer murine model led to tumor regression by CD8+ T lymphocyte activation and the expression of chemokines such as CXCL5, CXCL2, CCL8, and CCL5 [126].